Recent data suggest that a time lag exists between nuclear penetration and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-directed gene editing activity in human cells. As CRISPR/Cas approaches clinical implementation, it is critical to establish a biological time frame in which the complex enters the cell and nucleus and executes its gene editing function. We are developing CRISPR-directed gene editing for the treatment of non-small cell lung carcinoma focusing Nuclear Factor Erythroid 2-Related Factor-Like (NRF2), a transcription factor which regulates chemoresistance. In this report, we define cellular events that surround the initialization of CRISPR-directed gene editing as a function of time. We analyze the efficiency of cellular transfection of both components of the RNP particle and assess the emergence of indels. For the first time, we image the nuclear positioning of the tracrRNA and Cas9 as a complex and as individual gene editing components. Our results indicate that while the nuclear localization of the CRISPR/Cas complex is efficient and rapid, disruption of the NRF2 gene appears four to eight hours later. We reveal an initial snapshot of the schedule and processing of CRISPR/Cas in a lung cancer cell; information that will be useful as cell-based protocols are designed and advanced.
Introduction
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-directed gene editing is having a major impact on biomedical research and is already being translated into the clinic. The USA FDA has approved its use in clinical trials and similar organizations in Europe and China have done the same. The paradigm from bench to bedside has been undoubtedly accelerated because of the success and excitement that surrounds this technology. Yet, fundamental questions surrounding the mechanism of action and regulatory circuitry remain unanswered. Recently, reports have begun to appear reflecting the fact that many technological advances are not robust to be used in a broad-based format and are often reproducible only by those who discover them 1 . To improve reproducibility and achieve technological robustness, it is important that we elucidate foundational aspects of reaction mechanics that could clearly impact the clinical application of this technology.
We have begun to investigate the feasibility of using CRISPR-directed gene editing in combination with current standard of care for the treatment of solid tumors including non-small cell lung carcinoma (NSCLC). Our initial approach has been decidedly reductionist wherein we created a CRISPR/Cas9 gene editing tool to disable the Nuclear Factor Erythroid 2-Related Factor-Like (NRF2) gene. NRF2 is a master regulator of 100-200 target genes involved in cellular responses to oxidative/electrophilic stress 2, 3 . NRF2 is also known to regulate the expression of genes involved in protein degradation and detoxification and is negatively regulated by Kelch-like ECH-associated protein 1 (KEAP1), a substrate adapter for the Cul3dependent E3 ubiquitin ligase complex. NRF2 expression increases significantly when a NSCLC patient is treated with chemotherapy through an activation of target genes that trigger the cyto-protective response. Several studies have demonstrated that increased NRF2 expression is one of the major contributing factors of chemo-resistance in cancer cells and more prevalent in NSCLC [3] [4] [5] [6] [7] [8] . We previously discovered that successful functional knockout of the NRF2 gene in chemo-resistant lung cancer cells significantly increased the anticancer activity of cisplatin, carboplatin and vinorelbine in both cell culture and mouse models 9 . Our results prompted testing the feasibility of innovative therapeutic approaches for clinical development to reduce clinical side effects associated with chemotherapy 10 . This strategy centers on a combinatorial approach in which gene editing would disable the NRF2 gene removing its global regulation of chemoresistance.
Recent data suggest that a time lag exists between nuclear penetration and the appearance of gene editing activity in human cells 11 . For clinical implementation, it is essential that a biological time frame in which the complex enters the cell, penetrates the nuclease and executes its gene editing function is established. In this report, we carry out a series of experiments to elucidate important reaction parameters that surround the coupling of nuclear penetration and gene editing activity. Our results indicate that the localization of the exogenously added CRISPR/Cas complex into the nucleus of the lung tumor cell is efficient and rapid; however, evidence of NRF2 gene disruption begins to appear after about eight hours as the gene editing components are seen exiting the nucleus. Our results provide, for the first time, a snapshot of the time-series and processing of CRISPR/Cas in a lung cancer cell, information that will be useful as clinical protocols are designed, developed and advanced.
Results
We sought to examine the temporal relationship among nuclear localization, transit and gene editing activity vis-à-vis indel formation on the clinically relevant gene NRF2. To do so, we developed a CRISPR-directed gene editing strategy to target within the Neh2 domain of NRF2, encoded by Exon 2, using a dual fluorescently tagged CRISPR/Cas9 ribonucleoprotein (RNP) complex; the tracrRNA contained an ATTO 550 label and purified Cas9 protein was tagged with GFP ( Figures 1A and B ). After cell preparation and RNP assembly, A549 cells were transfected by Nucleofection with the dual labeled particle. After a designated period of time, we examined the targeted cell population by 1) FACS for single and dual transfection efficiency of the ribonucleoprotein components ( Figure 1C) , 2) fluorescent microscopy to visualize cellular and nuclear uptake, 3) western blot analysis for the presence and sustainability of Cas9 protein, and 4) gene editing activity on the NRF2 gene using the Tracking of Indel DEcomposition (TIDE) program 12 .
Fluorescent Activated Cell Sorting (FACS) provides an analysis of the transfection efficiency and cellular uptake by visualizing all four quadrants for co-localization of the ATTO 550 and GFP fluorescence tags respectively (Figure 2) . The red area (P1) of each left-hand graph depicts the cells that were collected and further analyzed for fluorescent intensity (right-hand graph). The Y axis (FITC channel) represents GFP fluorescence intensity and the X axis (PE channel) represents ATTO 550 fluorescence intensity. Quadrant 1 (Q1) contains cells positive for only GFP (Cas9) while quadrant 2 (Q2), which is highlighted in green, reflects cells containing both GFP and ATTO 550 (tracrRNA) fluorescence. Quadrant 3 (Q3) contains cells that do not exceed background fluorescence and quadrant 4 (Q4) contains cells positive for only ATTO 550 (tracrRNA). The table under each plot contains raw data from each quadrant. The fluorescence (%) found in quadrant 2 is of particular interest because this population represents cells that contain both fluorescent tags, presumably a co-localization of the two components of the RNP complex.
The total number of cells with both fluorescent signals in quadrant 2 is seen to decrease over time with the maximal level observed at one-hour post nucleofection; a significant drop is seen between four and eight hours. The totality of fluorescent cells in quadrant 2 and quadrant 4 remain consistent throughout most of the reaction time (until 12 hours) indicating that the cells receiving the RNP gradually lose GFP fluorescence first, while retaining ATTO 550 fluorescence for a longer period of time. These results suggest both labels are inside the targeted cell population for approximately one to four hours. The presence of intact Cas9 protein in the cell, as viewed by western blot, confirms this time frame (see Figure 4C ).
To measure gene editing activity, exon 2 was amplified, Sanger sequenced and analyzed by TIDE to quantify indel formation of the total unsorted population of transfected cells (Figure 3) . Indel formation appears to rise slowly, but steadily, throughout the course of the reaction with significant levels visible only after 8 hours, coincident with the increase in fluorescent signal of quadrant 4 of the FACS plots ( Figure 2 ).
While the timeframe of transfection efficiency and gene editing activity is informative, they are indirect measures of the RNP transit inside the cell, particularly with regard to possible nuclear localization. Therefore, we imaged nuclear entry, co-localization and exit of the RNP components by fluorescent microscopy at various time points (Figure 4A ). Brightness and contrast are enhanced for better visualization of the fluorescent RNP components (see also Supplemental Figure 1 ). Cells were stained with Hoechst 33258 to visualize the nucleus using the DAPI channel while fluorescent CRISPR complex components were visualized using GFP and DsRed channels respectively. The tracrRNA (ATTO 550) localizes rapidly into the nucleus while Cas9 (GFP) appears punctate at the nuclear membrane, merging or coalescing into the nucleus after four hours. Between one and eight hours, tracrRNA (ATTO 550) fluorescence appears throughout the nucleus and cytoplasm, and after eight hours, both Cas9 and tracrRNA appear to exit the cell. At twenty-four hours, Cas9 (GFP) is barely visible apart from the punctate remnants surrounding the nucleus and only small traces of tracrRNA (ATTO 550) remain visible in the nucleus. After forty-eight hours, both fluorescent components anywhere in the cell are barely detectable even with enhancement. When transfected with a single labeled RNP, GFP-fluorescing cells are located primarily in quadrant 1 after one hour and slowly disappear from all quadrants over eight hours, indicating degradation through loss of signal. Similarily, ATTO 550-fluorescing cells are observed at high levels in quadrant 4 after one hour and gradually diminish over the next twenty-four to forty-eight hours (see Supplemental Figure  2 ). Taken together, we are observing the decomposition of the CRISPR/Cas9 complex over time with Cas9 disappearing first, followed by the tracrRNA.
In Figure 4B , we present a graphical representation of the individual and dual fluorescence obtained from FACS analysis. Combining FACS analyses and indel formation data, the reaction could be generally broken down into two phases. Phase I encompasses RNP delivery and nuclear uptake along with the initial signals of CRISPR-directed DNA cleavage of a single target site; phase II reveals elevated levels of indel formation likely through resection and repair of the target site after cleavage, and the exit of the two fluorescent RNP components from the cell. Figure 4C represents Cas9 protein expression at each time point through Western blot analysis using an antibody directed against SpCas9. In our hands, the majority of Cas9 protein appears in the first four hours after introduction into the cell and becomes undetectable somewhere between four and eight hours after transfection.
Discussion
We provide a glimpse of the cellular events that surround the initialization of CRISPR-directed gene editing of a clinically relevant gene. We analyze the efficiency of cellular transfection of an RNP particle bearing differential fluorescent labels. We also assess the emergence of indels and, for the first time, we image the nuclear positioning of the tracrRNA and Cas9 as a complex and as individual gene editing components relative to indel formation. Our results indicate that gene editing may take place in at least two definable phases. Our data suggest that Cas9 levels diminish significantly between four and eight hours which correlates to their exit from the nucleus. In contrast, the fluorescently labeled tracrRNA transits into the nucleus rapidly and remains for up to eight hours. Both fluorescent labels eventually appear as punctate particles on the nuclear membrane at twelve hours prior to being diluted and rendered undetectable between twenty-four and forty-eight hours. Quadrant 1 reveals almost no GFP fluorescence indicating that Cas9 is likely complexed with tracrRNA after introduction into the cell. Supplemental data (Supplemental Figure 2 ) confirm that the Cas9 (GFP) molecule is detectable in quadrant 1 when transfected in the absence of other fluorescent components. Fluorescence in quadrant 4 increases over twelve hours as the dual label fluorescence in quadrant 2 diminishes over that same time period. After twelve hours, total fluorescence, the sum of quadrant 1, 2 and 4 respectively, declines precipitously correlating with the images provided by fluorescent microscopy.
The initialization of genetic disruption through gene editing begins with a CRISPR/Cas complex aligning in homologous register with a target gene, facilitating site-specific double-stranded DNA breakage [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] . Double stranded DNA breaks are most often repaired through a process known as Non-Homologous End Joining (NHEJ), an imperfect and unfaithful process in which nucleotides are lost or gained, generating functional knockouts. Contrasting data centered around the question of how long it takes for double-strand breaks to be created and repaired has been published with bulk measurements consistently showing that double-strand breaks have a half-life of ten to sixty minutes [23] [24] [25] [26] [27] [28] . However, these measurements lack the sensitivity that is required to follow double-strand breaks occurring and being repaired at a single locus, the reaction mechanics of CRISPR/Cas9. A crude estimate from Kim et al 29 suggested that indel formation by CRISPR/Cas occurs early in the process but is detected only after about fifteen hours. These data align with the belief that sequence specific nucleases direct indel formation only after multiple cycles of breakage and perfect repair 11 . Our data suggest that the time delay between penetration of the nucleus and detectable gene editing activity centers around four to eight hours, an observation that aligns with those made by Reid et al 30 .
Multiple pathways contribute to the repair of a Cas9 induced double-strand break 31 and relative activity of each is dependent on the locus, the metabolic state of the cell, and the half-life of the bound CRISPR complex. Indel formation likely emerges after multiple rounds of cleavage and repair once the cell has extinguished its energy supply which then causes error-prone repair of the double-strand breaks. It is possible that NHEJ initially prevents access of the Microhomology-mediated End Joining (MMEJ) pathway proteins to the double-strand break. Only after several hours wherein nonhomologous end joining has failed to repair the break, does the MMEJ pathway engage. We detect gene editing activity several hours after the RNP particle has successfully been transduced to the nucleus, a timeframe that aligns with the reaction mechanics of NHEJ and MMEJ.
Our data suggest an inverse relationship among important steps in the gene editing reaction: cellular uptake, nuclear localization of multiple components, indel formation and particle and/or component exit. These observations could help predict the timeframe of successful and impactful gene editing of the human genome. This information will be valuable to practitioners of clinical gene editing so that experimental protocols can be designed to maximize the desired outcome of genetic engineering in humans.
MATERIALS AND METHODS

Cell Line and Culture Conditions
Human lung carcinoma A549 cells were purchased from ATCC (#CCL-185) (Manassas, VA, USA). Cells were thawed, according to the manufacturer's protocol, and grown in F-12K medium (ATCC, Manassas, VA, USA) supplemented with 10% fetal bovine serum (FBS) (ATCC, Manassas, VA, USA) and 1% Penicillin-Streptomycin Solution (ATCC, Manassas, VA, USA) and incubated at 37 o C and 5% CO2.
CRISPR/Cas9 RNP Design and Assembly
The NRF2 gene-coding sequence was entered into Benchling (https://benchling.com) and the gRNA 5' TGGATTTGATTGACATACTT 3' within exon 2 was selected. The GFP-labeled SpCas9 protein was a kind gift from Integrated DNA Technologies (Coralville, Iowa). Unlabeled SpCas9, ATTO 550-labeled tracrRNA and designed crRNA were purchased from Integrated DNA Technologies. RNA oligos (crRNA and tracrRNA) were mixed in equimolar concentrations to a final duplex concentration of 20μM, then annealed by heating the mix at 95 C for 5 minutes and cooled to room temperature (15-25 C) . Prior to mixing with cells, crRNA:tracrRNA duplex (20μM working solution) and spCas9 protein (62μM stock solution) were mixed together for a final complexed concentration of 20 pmol and set to incubate at room temperature for 15 minutes.
Transfection of Labeled CRISPR/Cas9 RNP
The Lonza SF Cell Line 4D-Nucleofector X Kit (Lonza Inc, Basel, Switzerland) was used for transfection of the RNP in the A549 cell line. For all experiments, A549 cells were seeded 48 hours prior to transfection and allowed to reach 60-80% confluency. On the day of transfection, A549 cells were harvested by trypsinization and washed twice with 1x PBS (-/-). Cells were resuspended at a concentration of 3x10 5 cells/20μL in SF/supplement solution and 5μL of 20 pmol labeled RNP complex was added for each sample. Lonza program CM-130 was used and after 15 minutes of rest, cells were transferred to a 6-well plate or a 1.5ml tube for further analysis.
Transfection Efficiency and Gene Editing Analysis
A549 RNP fluorescence was measured by BD FACSAria II (BD Biosciences, San Jose, CA). Cells were harvested by trypsinization, washed three times and resuspended in 1x PBS (-/-) for FACS analysis. Several controls were used to establish gates based on each fluorescent component. The controls consisted of mock transfection of A549 cells, transfection of RNP with Cas9 (GFP), and transfection of RNP with tracrRNA (ATTO 550). Gates were established based on these parameters. After FACS analysis, cellular genomic DNA was isolated from each sample using the DNeasy Blood and Tissue Kit (Qiagen, Cat. 69506). The region surrounding the CRISPR target site was PCR amplified using Q5 High-Fidelity 2X Master Mix (New England BioLabs, Cat. M0492) (762 bp, forward primer 5'-ATTAAACAAGGGTGGGATTTCTTCTC-3', reverse primer 5'-AACTCAGGTTAGGTACTGAACTCATCA-3'). The PCR reaction was purified using the QIAquick PCR Purification Kit (Qiagen, Cat. 28106) and sent out to GENEWIZ, LLC (South Plainfield, NJ) for Sanger Sequencing. The software program, TIDE, was used for bulk sequence analysis to assess indel efficiency 12 .
Western Blot Analysis
A549 cells were transfected with unlabeled Cas9 RNP as described above. Cells were harvested at the indicated time points and the western blot was carried out as previously described (Bialk et al). Primary antibody incubation was performed overnight on a shaker at 4 o C for Cas9 (1:5,000, Abcam ab210752), and GAPDH (1:10,000, Abcam ab8245), and secondary antibody (Jackson ImmunoResearch Laboratories, West Grove, PA, USA) incubations were all done 1 hr at room temperature at a 1:10,000 dilution. The protein bands were visualized via chemiluminescence using a SuperSignal West Dura Extended Duration ECL (Pierce) and detected on the LI-COR Odyssey FC.
Fluorescence Microscopy
Transfected A549 cells were seeded in 4-well chambers (LabTek II). Before imaging at each indicated time point, cells were washed twice with PBS (-/-) and incubated with Hoechst 33258 (1:10,000, Invitrogen, Cat. H3569) for a minimum of 15 minutes at room temperature in the dark. Chambers were imaged at 20x magnification using the DAPI (358 nm), GFP (488 nm), and DsRed (560 nm) channels on the Zeiss Axio fluorescent observer.Z1 microscope. Random fields were imaged and images were processed on the AxioVision software. The brightness and contrast of the images have been enhanced for better visualization. 
